Navilyst Medical Announces Entry into the Embolization Market with the Launch of its Embarc® Microcatheter

Share Article

Navilyst Medical announced its entry into the Embolization Market with the U.S. launch of its new Embarc® Microcatheter with Glyce™ Hydrophilic Coating. The new catheter is designed for use in small vessels and superselective anatomy during diagnostic and interventional procedures in the peripheral vasculature. This introduction makes Navilyst Medical the first company to offer a 1000 psi pressure rating across its entire line of microcatheters.

Embarc® Microcatheter with Glyce™ Hydrophilic Coating

Navilyst Medical announced its entry into the Embolization Market with the U.S. launch of its new Embarc® Microcatheter with Glyce™ Hydrophilic Coating. The new catheter is designed for use in small vessels and superselective anatomy during diagnostic and interventional procedures in the peripheral vasculature. This introduction makes Navilyst Medical the first company to offer a 1000 psi pressure rating across its entire line of microcatheters.

"The Peripheral Embolization space is an exciting and growing area offering the opportunity for improved outcomes across a wide range of procedures, many of which once required surgery and can now be treated less invasively with less risk, pain and recovery time for the patient," commented Ron Sparks, Chariman and CEO. "Continuing to make advancements in the devices used by Interventional Radiologists, in what is expected to surpass 140,000 procedures this year alone, is a critical part of improving patient outcomes."

Kink resistance when advancing and placing a microcatheter is a critical part of its performance. The Embarc Microcatheter's braided shaft construction and engineered tapered extrusion are designed to provide kink resistance at the hub, along the shaft and at the tip. Furthermore, this construction allows proximal advancement and optimal stability in embolic delivery and power injection while providing distal flexibility to navigate through tortuous anatomy.

The ultra-durable GLYCE™ Hydrophilic Coating on the catheter's outside surface increases trackability while an extruded PTFE liner affords smooth guidewire and embolic interface. Additional features include a formed distal tip designed for atraumatic advancement and swaged RO marker providing visibility under fluoroscopy and dimensional control for navigation in vessel selection.

For the clinician, the delivery catheter is the single most important conduit allowing access to distal vasculature within the body. This underscores the importance of continued investment in this area with the goal of achieving better outcomes for patients.

About Navilyst Medical

Navilyst Medical Inc., headquartered in Marlborough, MA, is a leading provider of innovative solutions for image-guided interventions designed to deliver superior outcomes and reduce healthcare costs for medical professionals and their patients. Its breakthrough devices include BioFlo™ PICCs, available for sale in Canada and Europe, and PICCs and Ports with PASV® Valve Technology, Xcela® Power Injectable PICCs and world-leading NAMIC® Fluid Management products. The Company distributes its products globally and has its U.S. manufacturing facility in Glens Falls, NY. For more information, please visit: http://www.navilystmedical.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jill Robinson
Navilyst Medical
(508) 658-7990
Email >
Visit website